All Stories

  1. Rates of Lung Function Decline Differs Between COPD Phenotypes

    Article • September 2020, European Respiratory Society (ERS)

    Bernardino Alcazar Navarrete

  2. Clinical Features Of Women With COPD: Sex Differences In A Cross-Sectional Study In Spain (“The ESPIRAL-ES Study”)

    Article • International Journal of Chronic Obstructive Pulmonary Disease, November 2019, Taylor & Francis

    Dr Juan Antonio Riesco, Bernardino Alcazar Navarrete

  3. Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study

    Article • PLoS ONE, June 2018, PLOS

    Bernardino Alcazar Navarrete

  4. Atención médica según el nivel de riesgo y su adecuación a las recomendaciones de la guía española de la enfermedad pulmonar obstructiva crónica (EPOC) (GesEPOC): Estudio EPOCONSUL

    Article • Archivos de Bronconeumología, May 2018, Elsevier

    Bernardino Alcazar Navarrete

  5. Medical Care According to Risk Level and Adaptation to Spanish COPD Guidelines (GesEPOC): The Epoconsul Study

    Article • Archivos de Bronconeumología, May 2018, Elsevier

    Bernardino Alcazar Navarrete

  6. Geographic variations of the prevalence and distribution of COPD phenotypes in Spain: “the ESPIRAL-ES study”

    Article • International Journal of Chronic Obstructive Pulmonary Disease, April 2018, Dove Medical Press

    Bernardino Alcazar Navarrete, Dr Juan Antonio Riesco

  7. Óxido nítrico alveolar y bronquial en la enfermedad pulmonar obstructiva crónica y el solapamiento de asma y EPOC (ACO)

    Article • Archivos de Bronconeumología, April 2018, Elsevier

    Bernardino Alcazar Navarrete

  8. Management of COPD in End-of-Life Care by Spanish Pulmonologists

    Article • COPD Journal of Chronic Obstructive Pulmonary Disease, March 2018, Taylor & Francis

    Bernardino Alcazar Navarrete, Bernardino Alcazar Navarrete

  9. Evaluation of criteria for clinical control in a prospective, international, multicenter study of patients with COPD

    Article • Respiratory Medicine, March 2018, Elsevier

    Bernardino Alcazar Navarrete

  10. Clinical Guidelines in Asthma and Chronic Obstructive Pulmonary Disease: How Useful Are They in Clinical Practice?

    Article • Archivos de Bronconeumología, March 2018, Elsevier

    Bernardino Alcazar Navarrete

  11. Guías clínicas en asma y enfermedad pulmonar obstructiva crónica: ¿cuál es su utilidad en la práctica clínica?

    Article • Archivos de Bronconeumología, March 2018, Elsevier

    Bernardino Alcazar Navarrete

  12. Factors affecting the selection of an inhaler device for COPD and the ideal device for different patient profiles. Results of EPOCA Delphi consensus

    Article • Pulmonary Pharmacology & Therapeutics, February 2018, Elsevier

    Bernardino Alcazar Navarrete

  13. Anxiety, Depression, and Asthma Control: Changes After Standardized Treatment

    Article • The Journal of Allergy and Clinical Immunology In Practice, February 2018, Elsevier

    Bernardino Alcazar Navarrete, Dr francisco javier fj alvarez gutiérrez

  14. The Future of Triple Therapy in Chronic Obstructive Pulmonary Disease

    Article • Archivos de Bronconeumología, February 2018, Elsevier

    Bernardino Alcazar Navarrete

  15. Futuro de la triple terapia en la enfermedad pulmonar obstructiva crónica

    Article • Archivos de Bronconeumología, February 2018, Elsevier

    Bernardino Alcazar Navarrete

  16. Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD

    Article • European Respiratory Journal, January 2018, European Respiratory Society (ERS)

    Bernardino Alcazar Navarrete, Bernardino Alcazar Navarrete

  17. Variability in adherence to clinical practice guidelines and recommendations in COPD outpatients: a multi-level, cross-sectional analysis of the EPOCONSUL study

    Article • December 2017, Springer Science + Business Media

    Bernardino Alcazar Navarrete

  18. A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease

    Article • November 2017, Springer Science + Business Media

    Bernardino Alcazar Navarrete

  19. Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study

    Article • Advances in Therapy, November 2017, Springer Science + Business Media

    Bernardino Alcazar Navarrete

  20. Documento de expertos del uso de broncodilatadores inhalados en monoterapia en el tratamiento de la EPOC estable leve-moderada

    Article • Archivos de Bronconeumología, October 2017, Elsevier

    Bernardino Alcazar Navarrete

  21. Expert Statement on the Single-Agent Use of Inhaled Bronchodilator in the Treatment of Stable Mild-Moderate Chronic Obstructive Pulmonary Disease

    Article • Archivos de Bronconeumología, October 2017, Elsevier

    Bernardino Alcazar Navarrete

  22. Requirements, Strengths and Weaknesses of Inhaler Devices for COPD Patients from the Expert Prescribers' Point of View: Results of the EPOCA Delphi Consensus

    Article • COPD Journal of Chronic Obstructive Pulmonary Disease, September 2017, Taylor & Francis

    Bernardino Alcazar Navarrete

  23. FeNO is a valuable tool for managing COPD

    Article • September 2017, European Respiratory Society (ERS)

    Bernardino Alcazar Navarrete

  24. Concordance of opinions between patients and physicians and their relationship with symptomatic control and future risk in patients with moderate–severe asthma

    Article • BMJ Open Respiratory Research, September 2017, BMJ

    Bernardino Alcazar Navarrete, Dr francisco javier fj alvarez gutiérrez

  25. Validating the Concept of COPD Control: A Real-world Cohort Study from the United Kingdom

    Article • COPD Journal of Chronic Obstructive Pulmonary Disease, August 2017, Taylor & Francis

    Bernardino Alcazar Navarrete

  26. Active smoking and COPD phenotype: distribution and impact on prognostic factors

    Article • International Journal of Chronic Obstructive Pulmonary Disease, July 2017, Dove Medical Press

    Dr Juan Antonio Riesco, jose lorenzo, Bernardino Alcazar Navarrete, Bernardino Alcazar Navarrete

  27. Clinical audit of COPD in outpatient respiratory clinics in Spain: the EPOCONSUL study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, January 2017, Dove Medical Press

    Dr Juan José Soler-Cataluña, Jose Luis Lopez-Campos, Bernardino Alcazar Navarrete

  28. Evaluation of symptomatic patients without airflow obstruction: back to the future

    Article • Journal of Thoracic Disease, December 2016, AME Publishing Company

    Bernardino Alcazar Navarrete

  29. The evaluation of a remote support program on quality of life and evolution of disease in COPD patients with frequent exacerbations

    Article • BMC Pulmonary Medicine, November 2016, Springer Science + Business Media

    Bernardino Alcazar Navarrete

  30. 2016 Respiratory Effectiveness Group Annual Summit Report—impact & influence of real-world respiratory evidence

    Article • Journal of Thoracic Disease, July 2016, AME Publishing Company

    Bernardino Alcazar Navarrete

  31. Diagnostic performance of the measurement of nitric oxide in exhaled air in the diagnosis of COPD phenotypes

    Article • Nitric Oxide, April 2016, Elsevier

    Bernardino Alcazar Navarrete

  32. Validation of the ‘Test of the Adherence to Inhalers’ (TAI) for Asthma and COPD Patients

    Article • Journal of Aerosol Medicine and Pulmonary Drug Delivery, April 2016, Mary Ann Liebert Inc

    Bernardino Alcazar Navarrete, Dr. Concepción Fernández-Rodríguez, Dr Luis M Entrenas Costa

  33. Factors Associated with Depression in COPD: A Multicenter Study

    Article • Lung, March 2016, Springer Science + Business Media

    Bernardino Alcazar Navarrete

  34. Effect of Inhaled Corticosteroids on Salival Composition: A Cross-Sectional Study in Patients with Bronchial Asthma

    Article • Clinical Drug Investigation, August 2015, Springer Science + Business Media

    Bernardino Alcazar Navarrete

  35. The Effect of Incidental Consolidation on Management and Outcomes in COPD Exacerbations: Data from the European COPD Audit

    Article • PLoS ONE, July 2015, PLOS

    Dr sylvia hartl, Bernardino Alcazar Navarrete, Ady Angélica Castro-Acosta, Dr Konstantinos Panagiotis Bartziokas

  36. de Torres JP

    Article • International Journal of Chronic Obstructive Pulmonary Disease, July 2015, Dove Medical Press

    Dr Marc Miravitlles, Dr Juan José Soler-Cataluña, Dr Juan P. de Torres, Dr Luis M Entrenas Costa, Dr Cristobal Esteban, Dr francisco javier fj alvarez gutiérrez, Dra Milagros m Iriberri, Jose Luis Lopez-Campos, Bernardino Alcazar Navarrete, Bernardino Alcazar Navarrete, José Antonio Ros-Lucas

  37. Documento de consenso «Uso adecuado de los corticoides inhalados en la enfermedad pulmonar obstructiva crónica»

    Article • Archivos de Bronconeumología, April 2015, Elsevier

    Bernardino Alcazar Navarrete, Dr Pedro J Marcos

  38. “Correct Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease”: A Consensus Document

    Article • Archivos de Bronconeumología, April 2015, Elsevier

    Bernardino Alcazar Navarrete

  39. The concept of control of COPD in clinical practice

    Article • International Journal of Chronic Obstructive Pulmonary Disease, December 2014, Taylor & Francis

    Dr Marc Miravitlles, Dr Juan José Soler-Cataluña, Bernardino Alcazar Navarrete, Bernardino Alcazar Navarrete

  40. Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems

    Article • Health and Quality of Life Outcomes, September 2014, Springer Science + Business Media

    Mr Carles Forne, Bernardino Alcazar Navarrete

  41. Xerostomia relates to the degree of asthma control

    Article • Journal of Oral Pathology and Medicine, August 2014, Wiley

    Bernardino Alcazar Navarrete

  42. Control in COPD is achievable

    Article • European Respiratory Journal, July 2014, European Respiratory Society (ERS)

    Bernardino Alcazar Navarrete

  43. Multicentric study on the beta-blocker use and relation with exacerbations in COPD

    Article • Respiratory Medicine, May 2014, Elsevier

    Dr Pedro J Marcos, Bernardino Alcazar Navarrete

  44. Consenso sobre atención integral de las agudizaciones de la enfermedad pulmonar obstructiva crónica (ATINA-EPOC). Parte VI

    Article • Medicina de Familia SEMERGEN, March 2013, Elsevier

    Bernardino Alcazar Navarrete

  45. Factors associated with high healthcare resource utilisation among COPD patients

    Article • Respiratory Medicine, December 2012, Elsevier

    Sagrario Mayoralas Alises, Bernardino Alcazar Navarrete

  46. Repeated Aspergillusisolation in respiratory samples from non-immunocompromised patients not selected based on clinical diagnoses: colonisation or infection?

    Article • BMC Infectious Diseases, November 2012, Springer Science + Business Media

    Dr Maria-Jose Gimenez, Bernardino Alcazar Navarrete

  47. Consenso sobre atención integral de las agudizaciones de la enfermedad pulmonar obstructiva crónica (ATINA-EPOC). Parte IV

    Article • Medicina de Familia SEMERGEN, November 2012, Elsevier

    Bernardino Alcazar Navarrete

  48. Clinical Audit of COPD Patients Requiring Hospital Admissions in Spain: AUDIPOC Study

    Article • PLoS ONE, July 2012, PLOS

    Bernardino Alcazar Navarrete, Dr Pedro J Marcos

  49. Factores asociados a la hospitalización por exacerbación de la enfermedad pulmonar obstructiva crónica

    Article • Archivos de Bronconeumología, March 2012, Elsevier

    Sagrario Mayoralas Alises, Bernardino Alcazar Navarrete

  50. Calcificación metastásica pleural secundaria a hiperparatiroidismo secundario

    Article • Archivos de Bronconeumología, November 2011, Elsevier

    Bernardino Alcazar Navarrete

  51. Bronquiectasias tras colectomía en paciente con colitis ulcerosa y mutación del factor V Leiden

    Article • Archivos de Bronconeumología, April 2005, Elsevier

    Bernardino Alcazar Navarrete

  52. Neuropsychological Functioning Associated with High-Altitude Exposure

    Article • Neuropsychology Review, December 2004, Springer Science + Business Media

    Bernardino Alcazar Navarrete

  53. Hipertensión pulmonar tromboembólica crónica asociada a fibrosis endomiocárdica del ventrículo derecho

    Article • Archivos de Bronconeumología, August 2003, Elsevier

    Bernardino Alcazar Navarrete